Top

Reactions Weekly

Published in:

01-06-2022 | Methotrexate | Case report

Mercaptopurine/methotrexate/prednisone

Behavioural side effects and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Mack M, et al. CASE REPORT: CLADRIBINE THERAPY FOR REFRACTORY ROSAI-DORFMAN-DESTOMBES DISEASE WITH RENAL LESIONS. Pediatric Blood and Cancer 69 (Suppl.): S174-S175 (plus poster) abstr. 486, No. 2, Jun 2022. Available from: URL: http://doi.org/10.1002/pbc.29735 [abstract]

Title: Mercaptopurine/methotrexate/prednisone
Behavioural side effects and lack of efficacy: case report
Publication date: 01-06-2022
Publisher: Springer International Publishing
Keywords: Methotrexate
Methotrexate
Lymphadenopathy
Cladribine
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-17977-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Mercaptopurine/methotrexate/prednisone

Behavioural side effects and lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Midodrine

Antiplatelets/heparin

Everolimus/prednisolone/sunitinib

Benznidazole

Amphotericin-B

Antineoplastics